USPTO serial 88030446
QIASTAT-DX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 28, 2019
- Examiner
- KEAM, ALEX S
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with QIASTAT-DX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel M. Gurfinkel
Daniel M. Gurfinkel Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological reagents for industrial and scientific purposes; non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use; Chemical reagents for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances | ACTIVE | — |
| 005 | Diagnostic preparations for medical or veterinary purposes; diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; cartridges sold pre-filled with reagents and/or liquids for medical and medical diagnostic use; cartridges sold pre-filled with reagents for sample preparation and analysis for medical or veterinary diagnostic use; Single-use cartridges for medical diagnostic purposes, containing reagents and/or liquids for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers; cartridges sold pre-filled with reagents for breaking of cell material, nucleic acid purification, amplification and hybridization for medical or medical diagnostic use | ACTIVE | — |
| 009 | Single-use cartridges for clinical laboratory use containing nucleic acid extraction column and/or real time Polymerase Chain Reaction chambers | ACTIVE | — |
| 010 | Medical diagnostic apparatus and instruments for use in preparing blood, bodily fluid and human biological samples for further testing and for the detection and identification of pathogen nucleic acids in blood, bodily fluids and biological samples; Analyzers for medical use for analyzing blood, bodily fluids and human biological samples; Analyzers for medical diagnosis for analyzing blood, bodily fluids and human biological samples; Medical and clinical diagnosis apparatus and machines, namely, molecular and immunoassay analyzers for analyzing blood and bodily fluids; Testing instruments for medical diagnostic purposes, namely, analyzers for detection and identification of pathogen nucleic acids in blood, bodily fluids and human biological samples; Apparatus for carrying-out diagnostic tests for medical purposes for testing blood bodily fluids and human biological samples | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Qiagen GmbH
- Other trademarks owned by Qiagen GmbH
- Other trademarks owned by Qiagen GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named QIASTAT-DX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 2, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 2, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 2, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 25, 2025 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 28, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 28, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 12, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 12, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 20, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 5, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 5, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 5, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 5, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 5, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 30, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 22, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 9, 2019 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 7, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 7, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 7, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 7, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 7, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 31, 2018 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 31, 2018 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 31, 2018 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 26, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 11, 2018 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Sep 6, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 23, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 23, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jul 13, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 12, 2018 | NWAP | NEW APPLICATION ENTERED | — |